Central bankers used to be an investor’s best friend. Until inflation came along — now they only want to spend time with their new ‘friend’. But the betrayal is not yet complete. A bizarre focus on the unemployment rate could mark the central bankers’ transition to being your worst enemy in 2023.
Imugene shares rise 11% for new US patent relating to its lung cancer vaccination currently in clinical development.
Boron and lithium producer 5E Advanced Materials falls more than 3% in share price on the release of its second-quarter results.
Wednesday was a busy day for lower jaws. Powell spoke. Then, Biden spoke.It’s easy to make fun of Biden’s speech, so we will hop to it. The man has always been a hack. Now he’s an old hack. And old hacks are funnier than young ones.
Aussie coal makes it to China for the first time in two years. Thawing relations is opening up renewed trade opportunities. The winners of the old China boom may not be the same as the new ones. Farmers and fishermen could be the biggest winners of all…
ASX opens lower, mimicking Wall Street’s angst. REA flags drop in residential new listings. News Corp announces layoffs. Bitcoin stumbles.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988
